These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2053166)

  • 1. Experience with aluminum-associated bone disease in end-stage renal disease patients.
    Joglar FM; Rivera CG; Burgos R; Huffer WE
    Transplant Proc; 1991 Apr; 23(2):1823-4. PubMed ID: 2053166
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention and treatment of aluminum intoxication in chronic renal failure.
    Simon P; Allain P; Ang KS; Cam G; Mauras Y
    Adv Nephrol Necker Hosp; 1985; 14():439-78. PubMed ID: 3919543
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bone disorders in children with chronic renal insufficiency exposed to high ingestion of aluminum].
    Gordillo-Paniagua G; Valencia-Mayoral P; Mercado L; Medina-Mercado M
    Bol Med Hosp Infant Mex; 1990 May; 47(5):336-41. PubMed ID: 2390188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aluminum: a pediatric overview.
    Gruskin AB
    Adv Pediatr; 1988; 35():281-330. PubMed ID: 3055861
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of plasma aluminum in the detection and prevention of aluminum toxicity.
    Winney RJ; Cowie JF; Robson JS
    Kidney Int Suppl; 1986 Feb; 18():S91-5. PubMed ID: 3458005
    [No Abstract]   [Full Text] [Related]  

  • 6. [Aluminum poisoning].
    Cervar M; Stavljenic A; Vukicević S
    Lijec Vjesn; 1989; 111(4-5):164-9. PubMed ID: 2671563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved bone formation in dialysis patients after substitution of calcium carbonate for aluminum gels.
    Hercz G; Andress DL; Norris KC; Shinaberger JH; Slatopolsky EA; Sherrard DJ; Coburn JW
    Trans Assoc Am Physicians; 1987; 100():139-46. PubMed ID: 3455064
    [No Abstract]   [Full Text] [Related]  

  • 8. The efficacy of various treatment modalities on aluminium associated bone disease.
    Ihle BU; Buchanan MR; Stevens B; Becker GJ; Kincaid-Smith P
    Proc Eur Dial Transplant Assoc; 1983; 19():195-202. PubMed ID: 6348735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aluminum-associated bone disease: what's in a name?
    Quarles LD; Gitelman HJ; Drezner MK
    J Bone Miner Res; 1986 Oct; 1(5):389-90. PubMed ID: 3503553
    [No Abstract]   [Full Text] [Related]  

  • 10. Continuous ambulatory peritoneal dialysis: three years' experience.
    Ramos JM; Gokal R; Siamopolous K; Ward MK; Wilkinson R; Kerr DN
    Q J Med; 1983; 52(206):165-86. PubMed ID: 6611839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aluminum-related bone disease in chronic hemodialysis patients].
    Jara A; Rosenberg H; Bruhn C; Vaccarezza A; Vial S; Jalil R; Cisternas H
    Rev Med Chil; 1993 Jul; 121(7):769-76. PubMed ID: 8296081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired cystic disease of the kidney in patients with end-stage chronic renal failure: a study of prevalence and aetiology.
    Thomson BJ; Jenkins DA; Allan PL; Elton RA; Winney RJ
    Nephrol Dial Transplant; 1986; 1(1):38-43. PubMed ID: 3110661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum immunoreactive erythropoietin in patients with end stage renal disease.
    Gimenez LF; Watson AJ; Spivak JL
    Prog Clin Biol Res; 1990; 352():493-504. PubMed ID: 2402519
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative morbidity among hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Churchill DN
    Kidney Int Suppl; 1993 Feb; 40():S16-22. PubMed ID: 8445834
    [No Abstract]   [Full Text] [Related]  

  • 15. [Calcific periarthritis in patients with endstage renal disease on chronic dialysis].
    Hausmann MJ; Zlotnik M; Chaimovitz C; Sukenik S
    Harefuah; 1992 Apr; 122(8):497-500, 551. PubMed ID: 1398314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialysis encephalopathy secondary to aluminum toxicity, diagnosed by bone biopsy.
    Andrade LG; Garcia FD; Silva VS; Gabriel DP; Rodrigues AG; Nascimento GV; Caramori JT; Martin LC; Barretti P; Balbi AL
    Nephrol Dial Transplant; 2005 Nov; 20(11):2581-2. PubMed ID: 16105866
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bone and soft tissue damage in patients with chronic renal failure during treatment by systematic hemodialysis].
    Nenov D; Kolev Z; Vicheva S
    Urol Nefrol (Mosk); 1984; (6):53-6. PubMed ID: 6516077
    [No Abstract]   [Full Text] [Related]  

  • 18. Aluminum and renal bone disease in Australia.
    Dunstan CR; Evans RA
    Kidney Int Suppl; 1986 Feb; 18():S65-9. PubMed ID: 3457999
    [No Abstract]   [Full Text] [Related]  

  • 19. Continuous ambulatory peritoneal dialysis in end-stage renal disease.
    Chaimovitz C; Zimlichman R; Zlotnik M
    Isr J Med Sci; 1983 Jun; 19(6):575-6. PubMed ID: 6862870
    [No Abstract]   [Full Text] [Related]  

  • 20. Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Joffe P; Olsen F; Heaf JG; Gammelgaard B; Pödenphant J
    Clin Nephrol; 1989 Sep; 32(3):133-8. PubMed ID: 2791364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.